ArticleBlood2012

Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.

Deborah J Kuhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.